GENO.ST
Genovis AB
Price:  
25.25 
SEK
Volume:  
28,243.00
Sweden | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GENO.ST Relative Valuation

-45.7%
Upside

As of 2024-12-12, the Relative Valuation of Genovis AB (GENO.ST) is 13.70 SEK. This relative valuation is based on P/E multiples. With the latest stock price at 25.25 SEK, the upside of Genovis AB based on Relative Valuation is -45.7%.

The range of the Relative Valuation is 6.35 - 25.23 SEK.

Range Selected
Trailing P/E multiples 24.1x - 43.2x 33.7x
Forward P/E multiples 16.0x - 34.1x 25.0x
Fair Price 6.35 - 25.23 13.70
Upside -74.9% - -0.1% -45.7%
25.25 SEK
Stock Price
13.70 SEK
Fair Price

GENO.ST Relative Valuation - Historical P/E Data

Date P/E
2024-12-06 94.69
2024-12-05 91.08
2024-12-04 94.50
2024-12-03 93.17
2024-12-02 95.26
2024-11-29 99.62
2024-11-28 100.38
2024-11-27 96.21
2024-11-26 103.99
2024-11-25 105.31
2024-11-22 106.45
2024-11-21 103.23
2024-11-20 104.75
2024-11-19 104.93
2024-11-18 106.45
2024-11-15 104.37
2024-11-14 103.61
2024-11-13 100.57
2024-11-12 101.71
2024-11-11 101.52
2024-11-08 96.59
2024-11-07 75.90
2024-11-06 76.09
2024-11-05 81.97
2024-11-04 83.11
2024-11-01 82.54
2024-10-31 82.54
2024-10-30 83.68
2024-10-29 85.20
2024-10-28 83.87
2024-10-25 83.49
2024-10-24 84.25
2024-10-23 83.11
2024-10-22 85.01
2024-10-21 87.10
2024-10-18 86.53
2024-10-17 88.05
2024-10-16 86.91
2024-10-15 87.86
2024-10-14 89.19
2024-10-11 89.94
2024-10-10 89.75
2024-10-09 89.56
2024-10-08 90.89
2024-10-07 93.55
2024-10-04 94.88
2024-10-03 96.59
2024-10-02 100.57
2024-10-01 98.86
2024-09-30 103.23